Zu-Sen Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zu-Sen Wang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Chang-Lei Li
Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
5 shared publicationsAo Sun
Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
4 shared publicationsChanglei Li
Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
4 shared publications- Jingyu Cao
Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
4 shared publications - Liqun Wu
Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China
3 shared publications Xiaotong Cui
Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
3 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Comparison of transumbilical single-port and conventional multi-port laparoscopic hepatectomy for benign liver lesions
- 24 August 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Open AccessComparison of transumbilical single-port and conventional multi-port laparoscopic hepatectomy for benign liver lesions
- 14 January 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1881 (2) , 189532
Protein palmitoylation and immune regulation in pancreatic ductal adenocarcinoma: Integrating insights from cross-cancer studies
- 14 January 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1881 (2) , 189532
Protein palmitoylation and immune regulation in pancreatic ductal adenocarcinoma: Integrating insights from cross-cancer studies
- Open Access
- 13 November 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e950370
Eosinophilic Gastroenteritis Accompanied with Partial Midgut Malrotation in an Adult: A Case Report
BACKGROUND Eosinophilic gastroenteritis (EGE) is a rare inflammatory condition characterized by eosinophilic infiltration of the gastrointestinal tract, often presenting with non-specific symptoms such as abdominal pain, diarrhea, and ascites. Midgut malrotation is a congenital anatomical anomaly typically diagnosed in infancy but may remain undetected until adulthood. The coexistence of EGE and partial midgut malrotation in an adult is extremely rare and has not been previously reported. CASE REPORT We report the case of a 25-year-old man who presented with persistent epigastric cramping pain and abdominal distension. Laboratory evaluation revealed marked eosinophilia, elevated C-reactive protein, and high total IgE levels. Abdominal contrast-enhanced CT showed duodenal wall thickening, mucosal edema, and abnormal positioning of the horizontal duodenum and proximal jejunum, suggestive of partial midgut malrotation. Endoscopy revealed congested, swollen mucosa with patchy erosions and narrowing at the duodenal bulb-descending junction. Histopathology confirmed eosinophilic infiltration in the duodenal and gastric mucosa. The patient was diagnosed with eosinophilic gastroenteritis accompanied by partial midgut malrotation. He was treated with corticosteroids and supportive care, resulting in significant clinical and hematologic improvement. CONCLUSIONS This case highlights a rare but important diagnostic consideration involving the coexistence of inflammatory and congenital anatomical gastrointestinal disorders. Clinicians should maintain a high level of suspicion for structural anomalies in adults presenting with unexplained gastrointestinal symptoms. Early multidisciplinary evaluation is essential for accurate diagnosis and appropriate management.
- 13 November 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e950370
Open AccessEosinophilic Gastroenteritis Accompanied with Partial Midgut Malrotation in an Adult: A Case Report
BACKGROUND Eosinophilic gastroenteritis (EGE) is a rare inflammatory condition characterized by eosinophilic infiltration of the gastrointestinal tract, often presenting with non-specific symptoms such as abdominal pain, diarrhea, and ascites. Midgut malrotation is a congenital anatomical anomaly typically diagnosed in infancy but may remain undetected until adulthood. The coexistence of EGE and partial midgut malrotation in an adult is extremely rare and has not been previously reported. CASE REPORT We report the case of a 25-year-old man who presented with persistent epigastric cramping pain and abdominal distension. Laboratory evaluation revealed marked eosinophilia, elevated C-reactive protein, and high total IgE levels. Abdominal contrast-enhanced CT showed duodenal wall thickening, mucosal edema, and abnormal positioning of the horizontal duodenum and proximal jejunum, suggestive of partial midgut malrotation. Endoscopy revealed congested, swollen mucosa with patchy erosions and narrowing at the duodenal bulb-descending junction. Histopathology confirmed eosinophilic infiltration in the duodenal and gastric mucosa. The patient was diagnosed with eosinophilic gastroenteritis accompanied by partial midgut malrotation. He was treated with corticosteroids and supportive care, resulting in significant clinical and hematologic improvement. CONCLUSIONS This case highlights a rare but important diagnostic consideration involving the coexistence of inflammatory and congenital anatomical gastrointestinal disorders. Clinicians should maintain a high level of suspicion for structural anomalies in adults presenting with unexplained gastrointestinal symptoms. Early multidisciplinary evaluation is essential for accurate diagnosis and appropriate management.
- Open Access
- 18 June 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1589455
Targeting super-enhancers in liver cancer: from pathogenic mechanisms to clinical applications
Liver cancer, especially primary liver cancer (PLC), stands as the third leading cause of cancer-related mortality globally, posing a significant threat to human health. Super-enhancers (SEs), clusters of enhancer elements with high histone modifications and transcriptional activity levels, play crucial roles in diverse biological processes and are closely associated with the pathogenesis of various diseases, including liver cancer. This review first delves into the pathogenic mechanisms of super - enhancers in liver cancer. SEs can drive the aberrant expression of oncogenes in liver cancer. Through interactions with transcription factors and chromatin-modifying enzymes, SEs can reshape the chromatin architecture, facilitating the access of transcriptional machinery to oncogene promoters and resulting in their overexpression. Additionally, abnormal activation of signaling pathways in liver cancer can also regulate the formation and activity of SEs, creating a positive - feedback loop that fuels tumor development. We further explore how targeting SEs may translate into clinical applications for liver cancer. Therapeutic strategies, such as using small inhibitors that disrupt the function of key components in SE-mediated transcriptional complexes, have shown promise in pre-clinical studies. These inhibitors can specifically block the activity of SEs, leading to the downregulation of oncogene expression and subsequent suppression of tumor cell growth. In addition, gene-editing technologies provide new tools for precisely modulating super-enhancer activity in liver cancer cells. By deleting or modifying specific enhancer elements within SEs, the expression of oncogenes can be effectively controlled. In conclusion, understanding the pathogenic mechanisms of SEs in liver cancer and their clinical applications offers a new perspective on the diagnosis, treatment, and prognosis of liver cancer. However, more in-depth research is required to fully realize the potential of super-enhancer-targeted therapy in clinical settings in order to provide more effective treatment options for liver cancer patients.
- 18 June 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1589455
Open AccessTargeting super-enhancers in liver cancer: from pathogenic mechanisms to clinical applications
Liver cancer, especially primary liver cancer (PLC), stands as the third leading cause of cancer-related mortality globally, posing a significant threat to human health. Super-enhancers (SEs), clusters of enhancer elements with high histone modifications and transcriptional activity levels, play crucial roles in diverse biological processes and are closely associated with the pathogenesis of various diseases, including liver cancer. This review first delves into the pathogenic mechanisms of super - enhancers in liver cancer. SEs can drive the aberrant expression of oncogenes in liver cancer. Through interactions with transcription factors and chromatin-modifying enzymes, SEs can reshape the chromatin architecture, facilitating the access of transcriptional machinery to oncogene promoters and resulting in their overexpression. Additionally, abnormal activation of signaling pathways in liver cancer can also regulate the formation and activity of SEs, creating a positive - feedback loop that fuels tumor development. We further explore how targeting SEs may translate into clinical applications for liver cancer. Therapeutic strategies, such as using small inhibitors that disrupt the function of key components in SE-mediated transcriptional complexes, have shown promise in pre-clinical studies. These inhibitors can specifically block the activity of SEs, leading to the downregulation of oncogene expression and subsequent suppression of tumor cell growth. In addition, gene-editing technologies provide new tools for precisely modulating super-enhancer activity in liver cancer cells. By deleting or modifying specific enhancer elements within SEs, the expression of oncogenes can be effectively controlled. In conclusion, understanding the pathogenic mechanisms of SEs in liver cancer and their clinical applications offers a new perspective on the diagnosis, treatment, and prognosis of liver cancer. However, more in-depth research is required to fully realize the potential of super-enhancer-targeted therapy in clinical settings in order to provide more effective treatment options for liver cancer patients.
- Open Access
- 22 May 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1606654
Bisphenols exposure and non-alcoholic fatty liver disease: from environmental trigger to molecular pathogenesis
Bisphenols (BPs), including bisphenol A (BPA) and its substitutes (BPS, BPF), are ubiquitous environmental contaminants with emerging links to metabolic disorders. This review synthesizes current evidence on the role of BP exposure in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), a global health crisis affecting 25% of adults worldwide. Epidemiological studies reveal significant positive associations between urinary/serum BP levels and NAFLD risk, particularly in males, with maternal exposure correlating to transgenerational metabolic dysfunction. Mechanistically, BPs disrupt hepatic lipid homeostasis by activating PPAR-γ and suppressing fatty acid oxidation while concurrently inducing insulin resistance via impaired IRS-1/PI3K/Akt signaling. Oxidative stress, NLRP3 inflammasome activation, and gut-liver axis perturbations further exacerbate steatosis and inflammation. Co-exposure with phthalates or high-fat diets amplifies hepatotoxicity, highlighting synergistic environmental risks. Critically, developmental and sex-specific susceptibility underscores the need for tailored interventions. We propose preventive strategies to mitigate NAFLD progression, including BP avoidance and policy reforms. This work bridges gaps between environmental epidemiology and molecular toxicology, emphasizing BPs as modifiable drivers of metabolic liver disease.
- 22 May 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1606654
Open AccessBisphenols exposure and non-alcoholic fatty liver disease: from environmental trigger to molecular pathogenesis
Bisphenols (BPs), including bisphenol A (BPA) and its substitutes (BPS, BPF), are ubiquitous environmental contaminants with emerging links to metabolic disorders. This review synthesizes current evidence on the role of BP exposure in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), a global health crisis affecting 25% of adults worldwide. Epidemiological studies reveal significant positive associations between urinary/serum BP levels and NAFLD risk, particularly in males, with maternal exposure correlating to transgenerational metabolic dysfunction. Mechanistically, BPs disrupt hepatic lipid homeostasis by activating PPAR-γ and suppressing fatty acid oxidation while concurrently inducing insulin resistance via impaired IRS-1/PI3K/Akt signaling. Oxidative stress, NLRP3 inflammasome activation, and gut-liver axis perturbations further exacerbate steatosis and inflammation. Co-exposure with phthalates or high-fat diets amplifies hepatotoxicity, highlighting synergistic environmental risks. Critically, developmental and sex-specific susceptibility underscores the need for tailored interventions. We propose preventive strategies to mitigate NAFLD progression, including BP avoidance and policy reforms. This work bridges gaps between environmental epidemiology and molecular toxicology, emphasizing BPs as modifiable drivers of metabolic liver disease.
- 12 February 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1880 (2) , 189286
Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review
- 12 February 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1880 (2) , 189286
Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review
- Open Access
- 11 February 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-16
Machine learning model reveals the risk, prognosis, and drug response of histamine-related signatures in pancreatic cancer
Background Histamine, a critical inflammatory mediator, is generated by both mast cells and specific tumor cells, and it plays a fundamental role in inflammatory and immune responses. In the current scientific landscape, histamine-related genes (HRGs) and their associated pathways have been validated to be implicated in the development and advancement of cancer. However, the precise role of HRGs in gauging the risk and predicting the prognosis of pancreatic adenocarcinoma (PAAD) remains nebulous. Methods We carried out an elaborate data collection endeavor. Transcriptome data along with pertinent clinical information were obtained from the GSE28735, GSE62452, and TCGA-PAAD cohorts. GWAS data were retrieved from the FinnGen Release 11 and eQTLGen databases. For the drug-target Mendelian randomization (MR) analysis, the “TwoSampleMR” (version 0.5.6) R package was employed. The random survival forest (RSF) model was analyzed using the “randomForestSRC (rfsrc)” R package and further elucidated with the help of the “mlr3” package. Somatic mutation analysis and immune infiltration investigations were conducted by means of the “maftools” (v. 2.12.0) R package and “pRRophetic” R software package, respectively. Targeted drug sensitivity analysis was executed using the “oncopredict” and “parallel” packages. Results Through a meticulous drug-targeted MR analysis and an exhaustive exploration of transcriptome databases (including 2 GSE combat and TCGA cohort), 20 upregulated differentially expressed genes (DEGs) were identified. The RSF model emerged as the optimal choice, and a 9-HRGs signature was selected to construct a prognostic model that boasted an average C-index of 0.777. In the training and validation cohorts, the model exhibited remarkable predictive prowess, with 1-, 2-, and 3-year prediction accuracies of 0.898, 0.932, and 0.922 in the training set, and 0.909, 0.974, and 0.962 in the validation set, respectively. A higher HRG score was found to correlate with adverse events and the N1 stage. Additionally, it was associated with an increase in M0 macrophages and a decline in CD8 + T cell function. For patients with a low HRG score, several commonly used chemotherapeutic agents, namely Gemcitabine, Carboplatin, Sorafenib, and Oxaliplatin, were more efficacious. Conclusion The HRG signature holds the potential to serve as effective biomarkers for diagnosing, predicting the prognosis, and assessing the sensitivity to chemotherapy in PAAD.
- 11 February 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-16
Open AccessMachine learning model reveals the risk, prognosis, and drug response of histamine-related signatures in pancreatic cancer
Background Histamine, a critical inflammatory mediator, is generated by both mast cells and specific tumor cells, and it plays a fundamental role in inflammatory and immune responses. In the current scientific landscape, histamine-related genes (HRGs) and their associated pathways have been validated to be implicated in the development and advancement of cancer. However, the precise role of HRGs in gauging the risk and predicting the prognosis of pancreatic adenocarcinoma (PAAD) remains nebulous. Methods We carried out an elaborate data collection endeavor. Transcriptome data along with pertinent clinical information were obtained from the GSE28735, GSE62452, and TCGA-PAAD cohorts. GWAS data were retrieved from the FinnGen Release 11 and eQTLGen databases. For the drug-target Mendelian randomization (MR) analysis, the “TwoSampleMR” (version 0.5.6) R package was employed. The random survival forest (RSF) model was analyzed using the “randomForestSRC (rfsrc)” R package and further elucidated with the help of the “mlr3” package. Somatic mutation analysis and immune infiltration investigations were conducted by means of the “maftools” (v. 2.12.0) R package and “pRRophetic” R software package, respectively. Targeted drug sensitivity analysis was executed using the “oncopredict” and “parallel” packages. Results Through a meticulous drug-targeted MR analysis and an exhaustive exploration of transcriptome databases (including 2 GSE combat and TCGA cohort), 20 upregulated differentially expressed genes (DEGs) were identified. The RSF model emerged as the optimal choice, and a 9-HRGs signature was selected to construct a prognostic model that boasted an average C-index of 0.777. In the training and validation cohorts, the model exhibited remarkable predictive prowess, with 1-, 2-, and 3-year prediction accuracies of 0.898, 0.932, and 0.922 in the training set, and 0.909, 0.974, and 0.962 in the validation set, respectively. A higher HRG score was found to correlate with adverse events and the N1 stage. Additionally, it was associated with an increase in M0 macrophages and a decline in CD8 + T cell function. For patients with a low HRG score, several commonly used chemotherapeutic agents, namely Gemcitabine, Carboplatin, Sorafenib, and Oxaliplatin, were more efficacious. Conclusion The HRG signature holds the potential to serve as effective biomarkers for diagnosing, predicting the prognosis, and assessing the sensitivity to chemotherapy in PAAD.
- Open Access
- 16 July 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 12 (20) , 4272-4288
Association of education with cholelithiasis and mediating effects of cardiometabolic factors: A Mendelian randomization study
Education, cognition, and intelligence are associated with cholelithiasis occur rence, yet which one has a prominent effect on cholelithiasis and which cardiome tabolic risk factors mediate the causal relationship remain unelucidated. To explore the causal associations between education, cognition, and intelligence and cholelithiasis, and the cardiometabolic risk factors that mediate the associations. Applying genome-wide association study summary statistics of primarily European individuals, we utilized two-sample multivariable Mendelian rando mization to estimate the independent effects of education, intelligence, and cogni tion on cholelithiasis and cholecystitis (FinnGen study, 37041 and 11632 patients, respectively; n = 486484 participants) and performed two-step Mendelian rando mization to evaluate 21 potential mediators and their mediating effects on the relationships between each exposure and cholelithiasis. Inverse variance weighted Mendelian randomization results from the FinnGen consortium showed that genetically higher education, cognition, or intelligence were not independently associated with cholelithiasis and cholecystitis; when adjusted for cholelithiasis, higher education still presented an inverse effect on cholecystitis [odds ratio: 0.292 (95%CI: 0.171-0.501)], which could not be induced by cognition or intelligence. Five out of 21 cardiometabolic risk factors were perceived as mediators of the association between education and cholelithiasis, including body mass index (20.84%), body fat percentage (40.3%), waist circumference (44.4%), waist-to-hip ratio (32.9%), and time spent watching television (41.6%), while time spent watching television was also a mediator from cognition (20.4%) and intelligence to cholelithiasis (28.4%). All results were robust to sensitivity analyses. Education, cognition, and intelligence all play crucial roles in the development of cholelithiasis, and several cardiometabolic mediators have been identified for prevention of cholelithiasis due to defects in each exposure.
- 16 July 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 12 (20) , 4272-4288
Open AccessAssociation of education with cholelithiasis and mediating effects of cardiometabolic factors: A Mendelian randomization study
Education, cognition, and intelligence are associated with cholelithiasis occur rence, yet which one has a prominent effect on cholelithiasis and which cardiome tabolic risk factors mediate the causal relationship remain unelucidated. To explore the causal associations between education, cognition, and intelligence and cholelithiasis, and the cardiometabolic risk factors that mediate the associations. Applying genome-wide association study summary statistics of primarily European individuals, we utilized two-sample multivariable Mendelian rando mization to estimate the independent effects of education, intelligence, and cogni tion on cholelithiasis and cholecystitis (FinnGen study, 37041 and 11632 patients, respectively; n = 486484 participants) and performed two-step Mendelian rando mization to evaluate 21 potential mediators and their mediating effects on the relationships between each exposure and cholelithiasis. Inverse variance weighted Mendelian randomization results from the FinnGen consortium showed that genetically higher education, cognition, or intelligence were not independently associated with cholelithiasis and cholecystitis; when adjusted for cholelithiasis, higher education still presented an inverse effect on cholecystitis [odds ratio: 0.292 (95%CI: 0.171-0.501)], which could not be induced by cognition or intelligence. Five out of 21 cardiometabolic risk factors were perceived as mediators of the association between education and cholelithiasis, including body mass index (20.84%), body fat percentage (40.3%), waist circumference (44.4%), waist-to-hip ratio (32.9%), and time spent watching television (41.6%), while time spent watching television was also a mediator from cognition (20.4%) and intelligence to cholelithiasis (28.4%). All results were robust to sensitivity analyses. Education, cognition, and intelligence all play crucial roles in the development of cholelithiasis, and several cardiometabolic mediators have been identified for prevention of cholelithiasis due to defects in each exposure.
- Open Access
- 6 December 2023
- Published by Springer Nature in Research Square
No Causal Association Between Cholelithiasis and COVID-19: A Bidirectional Mendelian Randomization Study
Background: Gallstone diseases and cholecystectomy are possibly associated with the severity of COVID-19 bidirectionally, yet the casual association remains unclear. Method: Applying genome-wide association study summary statistics of primarily European individuals, we utilized 2-sample Mendelian randomization to estimate the bidirectional causal effects of cholelithiasis, cholecystitis and cholecystectomy on three COVID-19 phenotypes: SARS-CoV-2 infection, COVID-19 hospitalization and severe COVID-19. Results: Inverse variance weighted Mendelian randomization results from the FinnGen consortium showed that none of cholelithiasis, cholecystitis and cholecystectomy was not causally associated with COVID-19 phenotypes, and vice versa. In addition, other methods including MR-Egger, weighted median, weight mode and simple mode exhibited approximate tendency as IVW. These results were all robust to sensitivity analysis. Conclusion: The forward MR analysis showed no causally significant impact of cholelithiasis, cholecystitis and cholecystectomy on COVID-19 phenotypes. Similarly, reverse MR results also showed no causal association between COVID-19 and cholelithiasis events.
- 6 December 2023
- Published by Springer Nature in Research Square
Open AccessNo Causal Association Between Cholelithiasis and COVID-19: A Bidirectional Mendelian Randomization Study
Background: Gallstone diseases and cholecystectomy are possibly associated with the severity of COVID-19 bidirectionally, yet the casual association remains unclear. Method: Applying genome-wide association study summary statistics of primarily European individuals, we utilized 2-sample Mendelian randomization to estimate the bidirectional causal effects of cholelithiasis, cholecystitis and cholecystectomy on three COVID-19 phenotypes: SARS-CoV-2 infection, COVID-19 hospitalization and severe COVID-19. Results: Inverse variance weighted Mendelian randomization results from the FinnGen consortium showed that none of cholelithiasis, cholecystitis and cholecystectomy was not causally associated with COVID-19 phenotypes, and vice versa. In addition, other methods including MR-Egger, weighted median, weight mode and simple mode exhibited approximate tendency as IVW. These results were all robust to sensitivity analysis. Conclusion: The forward MR analysis showed no causally significant impact of cholelithiasis, cholecystitis and cholecystectomy on COVID-19 phenotypes. Similarly, reverse MR results also showed no causal association between COVID-19 and cholelithiasis events.
- Open Access
- 14 November 2023
- Published by Springer Nature in Research Square
Associations of Education with Cholelithiasis and the Mediating Effects of Cardiometabolic Factors: A Mendelian Randomization Study
Background Education, cognition and intelligence are associated with cholelithiasis progression, yet which one has a prominent effect on cholelithiasis and which cardiometabolic risk factors mediate the causal relationship remain unelucidated. Method Applying genome-wide association study summary statistics of primarily European individuals, we utilized 2-sample multivariable Mendelian randomization to estimate the independent effects of education, intelligence, and cognition on cholelithiasis and cholecystitis (FinnGen study, 37041 and 11632 patients, respectively; n = 486484 participants) and performed 2-step Mendelian randomization to evaluate 21 potential mediators and their mediating effects on the relationships, between each exposure and cholelithiasis. Results Inverse variance weighted Mendelian randomization results from the FinnGen consortium showed that genetically higher education, cognition or intelligence were not independently associated with cholelithiasis and cholecystitis; when adjusted for cholelithiasis, higher education still presented an inverse effect on cholecystitis [OR: 0.292 (95% CI: 0.171 to 0.501)], which could not be induced by cognition or intelligence. Five out of 21 cardiometabolic risk factors were perceived as mediators of the association between education and cholelithiasis, including body mass index (20.84%), body fat percentage (40.3%), waist circumference (44.4%), waist-to-hip ratio (32.9%) and time spent watching television (41.6%); while time spent watching television was also a mediator from cognition (20.4%) and intelligence to cholelithiasis (28.4%). These results above were all robust to sensitivity analyses. Conclusion Education, cognition and intelligence all played crucial roles in the development of cholelithiasis, and several cardiometabolic mediators were identified as inferior targets for prevention of cholelithiasis due to defects in each exposure.
- 14 November 2023
- Published by Springer Nature in Research Square
Open AccessAssociations of Education with Cholelithiasis and the Mediating Effects of Cardiometabolic Factors: A Mendelian Randomization Study
Background Education, cognition and intelligence are associated with cholelithiasis progression, yet which one has a prominent effect on cholelithiasis and which cardiometabolic risk factors mediate the causal relationship remain unelucidated. Method Applying genome-wide association study summary statistics of primarily European individuals, we utilized 2-sample multivariable Mendelian randomization to estimate the independent effects of education, intelligence, and cognition on cholelithiasis and cholecystitis (FinnGen study, 37041 and 11632 patients, respectively; n = 486484 participants) and performed 2-step Mendelian randomization to evaluate 21 potential mediators and their mediating effects on the relationships, between each exposure and cholelithiasis. Results Inverse variance weighted Mendelian randomization results from the FinnGen consortium showed that genetically higher education, cognition or intelligence were not independently associated with cholelithiasis and cholecystitis; when adjusted for cholelithiasis, higher education still presented an inverse effect on cholecystitis [OR: 0.292 (95% CI: 0.171 to 0.501)], which could not be induced by cognition or intelligence. Five out of 21 cardiometabolic risk factors were perceived as mediators of the association between education and cholelithiasis, including body mass index (20.84%), body fat percentage (40.3%), waist circumference (44.4%), waist-to-hip ratio (32.9%) and time spent watching television (41.6%); while time spent watching television was also a mediator from cognition (20.4%) and intelligence to cholelithiasis (28.4%). These results above were all robust to sensitivity analyses. Conclusion Education, cognition and intelligence all played crucial roles in the development of cholelithiasis, and several cardiometabolic mediators were identified as inferior targets for prevention of cholelithiasis due to defects in each exposure.